The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function
Open accessAbstract
L-DOPA-induced dyskinesia is a major complication of L-DOPA pharmacotherapy in Parkinson's disease, and is thought to depend on abnormal cell signaling in the basal ganglia. In this study, we have addressed the possibility to model L-DOPA-induced dyskinesia in the mouse at both the behavioral and the molecular level. C57BL/6 mice sustained unilateral injections of 6-hydroxydopamine (6-OHDA) either in the medial forebrain bundle (MFB) or in the sensorimotor part of the striatum. Both types of lesion produced a similar degree of forelimb akinesia on the contralateral side of the body. The lowest dose of L-DOPA that could significantly relieve this akinetic deficit (i.e., 6 mg/kg) did not differ between MFB and intrastriatal lesions. The L-DOPA threshold dose for the induction of dyskinesia did however differ between the two lesion types. A daily dose of 6 mg/kg L-DOPA caused MFB lesioned mice to develop abnormal movements affecting orofacial, trunk, and forelimb muscles on the side contralateral to the lesion, whereas a daily dose of 18 mg/kg was required to produce comparable dyskinetic effects in the intrastriatally lesioned animals. The development of abnormal movements was accompanied by a striatal induction of DeltaFosB-like proteins and prodynorphin mRNA, that is, molecular markers that are associated with L-DOPA-induced dyskinesia in both rats and nonhuman primates. We conclude that 6-OHDA lesioned mice exhibit behavioral and cellular features of akinesia and L-DOPA-induced dyskinesia that are similar to those previously characterized in rats. The mouse model of L-DOPA-induced dyskinesia will provide a useful tool to study the molecular determinants of this movement disorder in transgenic mice strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,417
Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181402 · Cited by 1,953
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821
Self-citationLundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N., & Cenci, M. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01843.x · Cited by 664
Self-citationKirik, D., Rosenblad, C., & Björklund, A. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6848 · Cited by 663
Cenci, M. A., Lee, C. S., & Björklund, A. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00285.x · Cited by 641
Self-citationLevodopa motor complications in Parkinson's disease
Obeso, J. A., Olanow, C. W., & Nutt, J. G. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00031-8 · Cited by 478
Animal models of neurological deficits: how relevant is the rat?
Cenci, M. A., Whishaw, I. Q., & Schallert, T. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn877 · Cited by 456
Self-citationBehavioral phenotyping of the MPTP mouse model of Parkinson's disease
Sedelis, M., Schwarting, R. K. W., & Huston, J. P. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00309-6 · Cited by 432
Winkler, C., Kirik, D., Björklund, A., & Cenci, M. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0499 · Cited by 430
Self-citationSequence and expression of the rat prodynorphin gene.
Civelli, O., Douglass, J., Goldstein, A., & Herbert, E. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4291 · Cited by 383
Andersson, M., Hilbertson, A., & Cenci, M. A. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0259 · Cited by 350
Self-citationÅkerud, P., Canals, J. M., Snyder, E. Y., & Arenas, E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08108.2001 · Cited by 305
(2000) · Annals of Neurology · doi:10.1002/1531-8249(200001)47:1<2::aid-ana2>3.0.co;2-b · Cited by 249
Clinical and [18F] dopa PET findings in early Parkinson's disease.
Morrish, P. K., Sawle, G. V., & Brooks, D. J. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.6.597 · Cited by 245
Lee, C. S. (2000) · Brain · doi:10.1093/brain/123.7.1365 · Cited by 212
Genetic animal models: focus on schizophrenia
Gainetdinov, R. R., Mohn, A. R., & Caron, M. G. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01886-5 · Cited by 201
Henry, B., Crossman, A. R., & Brotchie, J. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6819 · Cited by 187
Doucet, J. ‐., Nakabeppu, Y., Bedard, P. J., Hope, B. T., Nestler, E. J., Jasmin, B. J., Chen, J. ‐., Ladarola, M. J., St‐Jean, M., Wigle, N., et al. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01220.x · Cited by 186
Levodopa therapy: Consequences of the nonphysiologic replacement of dopamine
Chase, T. N. (1998) · Neurology · doi:10.1212/wnl.50.5_suppl_5.s17 · Cited by 180
The mouse MPTP model: gene expression changes in dopaminergic neurons
Kühn, K., Wellen, J., Link, N., Maskri, L., Lübbert, H., & Stichel, C. C. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02408.x · Cited by 166
Schallert, T., & Tillerson, J. L. (2000) · Central Nervous System Diseases · doi:10.1007/978-1-59259-691-1_8 · Cited by 159
Andersson, M., Konradi, C. L., & Cenci, M. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09930.2001 · Cited by 145
Self-citationDissection of behavior and psychiatric disorders using the mouse as a model
Tarantino, L. M., & Bucan, M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.953 · Cited by 130
Persistent Behavioral Sensitization to Chronic l-DOPA Requires A2AAdenosine Receptors
Fredduzzi, S., Moratalla, R., Monopoli, A., Cuéllar, B., Xu, K., Ongini, E., Impagnatiello, F., Schwarzschild, M. A., & Chen, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01054.2002 · Cited by 128
Oral stereotypy induced by amphetamine microinjection into striatum: An anatomical mapping study
Dickson, P. R., Lang, C., Hinton, S. C., & Kelley, A. E. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90062-0 · Cited by 111
Whishaw, I. Q., Metz, G. A. S., Kolb, B., & Pellis, S. M. (2001) · Developmental Psychobiology · doi:10.1002/dev.1041 · Cited by 110
Tel, B. C., Zeng, B. ‐., Cannizzaro, C., Pearce, R. K. B., Rose, S., & Jenner, P. G. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00535-3 · Cited by 107
Cunningham, L. A., & Su, C. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7877 · Cited by 103
Andersson, M., Westin, J. E., & Cenci, M. A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02469.x · Cited by 84
Self-citationKostić, V., Marinković, J., Svetel, M. V., et al. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00346.x · Cited by 66
Steiner, H., & Kitai, S. T. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01756.x · Cited by 59
Bradley, A. (2002) · Nature · doi:10.1038/420512a · Cited by 40
Lindner, M. D., Plone, M. A., Francis, J. M., & Emerich, D. F. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(96)00027-5 · Cited by 38
Central nervous system diseases : innovative animal models from lab to clinic
Emerich, D. F., Dean, R. L., & Sanberg, P. R. (2000) · Humana Press eBooks · Cited by 27
Cited by
Toxin-induced models of Parkinson’s disease
Bové, J., Prou, D., Perier, C., & Przedborski, S. (2005) · NeuroRX · doi:10.1602/neurorx.2.3.484 · Cited by 739
The 6-Hydroxydopamine model of parkinson’s disease
Simola, N., Morelli, M., & Carta, A. R. (2007) · Neurotoxicity Research · doi:10.1007/bf03033565 · Cited by 514
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Self-citationSantini, E., Valjent, E., Usiello, A., Carta, M., Borgkvist, A., Girault, J.-A., Herve, D., Greengard, P., & Fisone, G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0852-07.2007 · Cited by 437
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice
Iancu, R., Mohapel, P., Brundin, P., & Paul, G. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.02.023 · Cited by 376
Metadata
- Authors
- Lundblad, M., Picconi, B., Lindgren, H., & Cenci, M. A.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 16
- Issue
- 1
- Pages
- 110-123
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2062319694
- Cited by
- 330
- References
- 35
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.